DARUNAVIR
NDC 68180-346, DARUNAVIR, tablet, film coated, from Lupin Pharmaceuticals, Inc..
- Product NDC
- 68180-346
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202073
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68180-346 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DARUNAVIR ETHANOLATE800 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; HIV Protease Inhibitors [MoA]; Protease Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68180-346-06 | 68180034606 | 30 TABLET, FILM COATED in 1 BOTTLE (68180-346-06) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/56daf67e-7501-4cd5-be22-566d7997d42eNADAC price for package 68180034606
GET /v1/drugs/nadac/68180034606
Use it
Look up 68180-346 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68180-346 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68180-346. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.